Roth Capital Forecasts Stronger Earnings for Aspen Aerogels

Aspen Aerogels, Inc. (NYSE:ASPN) – Analysts at Roth Capital increased their Q1 2025 earnings per share (EPS) estimates for Aspen Aerogels in a research note issued on Friday, November 8th. Roth Capital analyst C. Moore now forecasts that the construction company will earn $0.04 per share for the quarter, up from their prior estimate of $0.02. The consensus estimate for Aspen Aerogels’ current full-year earnings is $0.11 per share. Roth Capital also issued estimates for Aspen Aerogels’ Q3 2025 earnings at $0.23 EPS.

A number of other brokerages have also issued reports on ASPN. Benchmark restated a “buy” rating and issued a $14.00 target price on shares of Aspen Aerogels in a research note on Thursday, August 8th. Piper Sandler dropped their target price on Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 22nd. TD Cowen boosted their price target on shares of Aspen Aerogels from $36.00 to $41.00 and gave the stock a “buy” rating in a report on Tuesday, August 20th. Roth Mkm reduced their target price on Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating for the company in a report on Friday. Finally, Barclays initiated coverage on shares of Aspen Aerogels in a research note on Tuesday, August 6th. They issued an “overweight” rating and a $27.00 price target on the stock. One research analyst has rated the stock with a sell rating, nine have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, Aspen Aerogels has an average rating of “Moderate Buy” and a consensus target price of $28.90.

Aspen Aerogels Trading Up 4.8 %

Aspen Aerogels stock opened at $17.28 on Monday. The stock has a market cap of $1.33 billion, a PE ratio of 1,727.73 and a beta of 2.21. The company has a debt-to-equity ratio of 0.23, a quick ratio of 2.82 and a current ratio of 3.46. The stock has a 50-day moving average of $23.10 and a two-hundred day moving average of $24.73. Aspen Aerogels has a one year low of $8.79 and a one year high of $33.15.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the company. Point72 Hong Kong Ltd purchased a new position in shares of Aspen Aerogels in the 2nd quarter valued at about $84,000. nVerses Capital LLC purchased a new position in Aspen Aerogels in the second quarter valued at approximately $95,000. Quent Capital LLC acquired a new stake in Aspen Aerogels during the third quarter worth approximately $118,000. Point72 DIFC Ltd purchased a new stake in shares of Aspen Aerogels during the 2nd quarter worth approximately $121,000. Finally, Public Employees Retirement Association of Colorado acquired a new position in shares of Aspen Aerogels in the 2nd quarter valued at $145,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Insider Buying and Selling

In related news, CFO Ricardo C. Rodriguez sold 32,465 shares of the business’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $30.14, for a total value of $978,495.10. Following the sale, the chief financial officer now owns 20,790 shares in the company, valued at approximately $626,610.60. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, CFO Ricardo C. Rodriguez sold 32,465 shares of Aspen Aerogels stock in a transaction on Monday, August 26th. The stock was sold at an average price of $30.14, for a total value of $978,495.10. Following the completion of the transaction, the chief financial officer now directly owns 20,790 shares in the company, valued at approximately $626,610.60. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Donald R. Young sold 63,355 shares of the business’s stock in a transaction on Monday, September 30th. The stock was sold at an average price of $30.03, for a total value of $1,902,550.65. Following the transaction, the chief executive officer now directly owns 483,640 shares of the company’s stock, valued at $14,523,709.20. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.30% of the stock is currently owned by corporate insiders.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.